{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:35:10Z","timestamp":1791812110649,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3723,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/modpathol.2012.108","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T07:43:36Z","timestamp":1340955816000},"page":"1446-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["\u03b2-Adrenergic receptor expression in vascular tumors"],"prefix":"10.1016","volume":"25","author":[{"given":"Karen M","family":"Chisholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay W","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob B","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E","family":"Heerema-McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.108_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1067\/mjd.2003.200","article-title":"Hemangiomas of infancy","volume":"48","author":"Bruckner","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/modpathol.2012.108_bib2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/archderm.137.9.1208","article-title":"Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation","volume":"137","author":"Bennett","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/modpathol.2012.108_bib3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.108_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.arcped.2003.10.014","article-title":"Vincristine treatment for function- and life-threatening infantile hemangioma","volume":"11","author":"Enjolras","year":"2004","journal-title":"Arch Pediatr"},{"key":"10.1038\/modpathol.2012.108_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199507063330120","article-title":"Treatment of life-threatening infantile hemangiomas with vincristine","volume":"333","author":"Perez Payarols","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.108_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/jpsu.2001.25793","article-title":"Effective therapy of a vascular tumor of infancy with vincristine","volume":"36","author":"Moore","year":"2001","journal-title":"J Pediatr Surg"},{"key":"10.1038\/modpathol.2012.108_bib7","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/00006534-199911000-00002","article-title":"Complications of systemic corticosteroid therapy for problematic hemangioma","volume":"104","author":"Boon","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1038\/modpathol.2012.108_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(99)70104-6","article-title":"Toxicity profile of interferon alfa-2b in children: a prospective evaluation","volume":"135","author":"Dubois","year":"1999","journal-title":"J Pediatr"},{"key":"10.1038\/modpathol.2012.108_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0022-3476(98)70034-4","article-title":"Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy","volume":"132","author":"Barlow","year":"1998","journal-title":"J Pediatr"},{"key":"10.1038\/modpathol.2012.108_bib10","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.108_bib11","doi-asserted-by":"crossref","first-page":"195e","DOI":"10.1097\/PRS.0b013e3181a3f435","article-title":"Beta-blocking agent for treatment of infantile hemangioma","volume":"123","author":"Bigorre","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1038\/modpathol.2012.108_bib12","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"key":"10.1038\/modpathol.2012.108_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MOO.0b013e328332a4eb","article-title":"Propranolol treatment for infantile hemangiomas","volume":"17","author":"Buckmiller","year":"2009","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1038\/modpathol.2012.108_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PRS.0b013e3181c2a731","article-title":"Propranolol as first-line treatment for infantile hemangiomas","volume":"125","author":"Holmes","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1038\/modpathol.2012.108_bib15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00381-010-1153-7","article-title":"Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review","volume":"26","author":"Fulkerson","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"10.1038\/modpathol.2012.108_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/lary.20807","article-title":"Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center","volume":"120","author":"Buckmiller","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1038\/modpathol.2012.108_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpeds.2009.10.010","article-title":"Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma","volume":"156","author":"Truong","year":"2010","journal-title":"J Pediatr"},{"key":"10.1038\/modpathol.2012.108_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoceptors: an update","volume":"53","author":"Guimaraes","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1038\/modpathol.2012.108_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO;2-V","article-title":"cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation","volume":"67","author":"D'Angelo","year":"1997","journal-title":"J Cell Biochem"},{"key":"10.1038\/modpathol.2012.108_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2012.108_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.0000191541.06788.bb","article-title":"Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system","volume":"97","author":"Iaccarino","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/modpathol.2012.108_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2680.1997.00055.x","article-title":"Beta-adrenoceptor subtypes and their desensitization mechanisms","volume":"17","author":"Summers","year":"1997","journal-title":"J Auton Pharmacol"},{"key":"10.1038\/modpathol.2012.108_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.pharmthera.2005.12.002","article-title":"beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies","volume":"111","author":"Rozec","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1038\/modpathol.2012.108_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00059-002-2434-z","article-title":"The beta-adrenergic receptors","volume":"27","author":"Wallukat","year":"2002","journal-title":"Herz"},{"key":"10.1038\/modpathol.2012.108_bib25","first-page":"375","article-title":"Vascular tumors and vascular malformations (new issues)","volume":"13","author":"Enjolras","year":"1997","journal-title":"Adv Dermatol"},{"key":"10.1038\/modpathol.2012.108_bib26","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phases of hemangioma during infancy and childhood","volume":"93","author":"Takahashi","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2012.108_bib27","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/MPH.0b013e3182152e4e","article-title":"Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment","volume":"33","author":"Hermans","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1038\/modpathol.2012.108_bib28","doi-asserted-by":"crossref","unstructured":"Moss HB, Sines DT, Blatt J, et al. Epithelioid hemangioma responsive to oral propranolol. Ophthal Plast Reconstr Surg 2011; e-pub ahead of print.","DOI":"10.1097\/IOP.0b013e31823645f9"},{"key":"10.1038\/modpathol.2012.108_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijporl.2010.06.001","article-title":"Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm","volume":"74","author":"Truong","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1038\/modpathol.2012.108_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","article-title":"EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study","volume":"13","author":"Pirker","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222029568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222029568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:05:45Z","timestamp":1760231145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222029568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0893395222029568"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.108","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Adrenergic receptor expression in vascular tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}